Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

BACKGROUND: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. MATERIAL AND METHODS: We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Greither, Thomas, Fischer, Kersten, Theil, Gerit, Marcou, Marios, Holzhausen, Hans-Juergen, Weigelt, Katrin, Serrero, Ginette, Hicks, David, Yue, Binbin, Fornara, Paolo, Wullich, Bernd, Taubert, Helge, Wach, Sven, Lieb, Verena
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178934/
https://ncbi.nlm.nih.gov/pubmed/30323673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S172069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados